American Journal of Epidemiology Vol. 142, No. 7: 699-708
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health
other |
Gamma-glutamyltransferase: Determinants and Association with Mortality from Ischemic Heart Disease and All Causes
The association of serum levels of gamma-glutamyltransferase (GGT) with cardiovascular disease risk factors, and with mortality from all causes, cardiovascular disease, and non-cardiovascular diseases, has been examined in a prospective study of 7,613 middle-aged British men followed for 11.5 years. GGT levels were strongly associated with all-cause mortality, largely due to a significant increase in deaths from ischemic heart disease and other non-cardiovascular disease causes, i.e., non-cancer deaths, in the top quintile of the GGT distribution. No association was seen with cancer mortality. However, GGT was significantly (positively) associated with alcohol intake, body mass index, smoking, preexisting ischemic heart disease, diabetes mellitus, antihypertensive medication, systolic and diastolic blood pressure, total and high density lipoprotein cholesterol, heart rate, and blood glucose, and negatively associated with physical activity and lung function (forced expiratory volume in 1 second (FEV1)). After adjustment for these personal characteristics and biologic variables, elevated GGT (highest quintile 
24 unit/liter vs. the rest) was still associated with a significant increase in mortality from all causes (relative risk (RR) = 1.22, 95% confidence interval (Cl) 1.01–1.42; n = 818 deaths) and from ischemic heart disease (RR = 1.42, 95% Cl 1.12–1.80; n = 332 deaths). The increase in other non-cardiovascular disease causes was of marginal significance (RR = 1.45, 95% Cl 0.95–2.20; n = 127 deaths). When examined separately by the presence or absence of preexisting ischemic heart disease, the increased risk of ischemic heart disease mortality was more marked in those with evidence of ischemic heart disease at screening, particularly in those with previous myocardial infarction (RR = 1.67, 95% Cl 1.03–2.69; n = 84 deaths). The increased risk of other non-cardiovascular disease deaths was only seen in men without preexisting ischemic heart disease, largely due to an excess of hepatic cirrhosis. In summary, many factors other than alcohol intake are associated with increased levels of GGT, in particular body mass index, diabetes mellitus, and serum total cholesterol. The finding of increased risk of ischemic heart disease mortality seen in men with preexisting ischemic heart disease is related to the severity of the underlying myocardial damage. The biologic significance of raised GGT in men with preexisting ischemic heart disease merits further study. Am J Epidemiol 1995; 142:699–708.
gamma-glutamyltransferase;; ischemic heart disease;; mortality;; risk factors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Zhang and H. J. Forman Redox Regulation of {gamma}-Glutamyl Transpeptidase Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 509 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Poelzl, C. Eberl, H. Achrainer, J. Doerler, O. Pachinger, M. Frick, and H. Ulmer Prevalence and Prognostic Significance of Elevated {gamma}-Glutamyltransferase in Chronic Heart Failure Circ Heart Fail, July 1, 2009; 2(4): 294 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Strasak, C. C. Kelleher, J. Klenk, L. J. Brant, E. Ruttmann, K. Rapp, H. Concin, G. Diem, K. P. Pfeiffer, H. Ulmer, et al. Longitudinal Change in Serum Gamma-Glutamyltransferase and Cardiovascular Disease Mortality: A Prospective Population-Based Study in 76 113 Austrian Adults Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1857 - 1865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Strasak, K. Rapp, L. J. Brant, W. Hilbe, M. Gregory, W. Oberaigner, E. Ruttmann, H. Concin, G. Diem, K. P. Pfeiffer, et al. Association of {gamma}-Glutamyltransferase and Risk of Cancer Incidence in Men: A Prospective Study Cancer Res., May 15, 2008; 68(10): 3970 - 3977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Giral, N. Jacob, C. Dourmap, B. Hansel, A. Carrie, E. Bruckert, X. Girerd, and M. J. Chapman Elevated Gamma-Glutamyltransferase Activity and Perturbed Thiol Profile Are Associated With Features of Metabolic Syndrome Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fraser, R. Harris, N. Sattar, S. Ebrahim, G. D. Smith, and D.A. Lawlor Gamma-Glutamyltransferase Is Associated With Incident Vascular Events Independently of Alcohol Intake: Analysis of the British Women's Heart and Health Study and Meta-Analysis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2729 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Wallace, K. M. Utzschneider, J. Tong, D. B. Carr, S. Zraika, D. D. Bankson, R. H. Knopp, and S. E. Kahn Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat Diabetes Care, October 1, 2007; 30(10): 2673 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Targher, L. Bertolini, S. Rodella, R. Tessari, L. Zenari, G. Lippi, and G. Arcaro Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients Diabetes Care, August 1, 2007; 30(8): 2119 - 2121. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-S. Lim, D.-H. Lee, J.-Y. Park, S.-H. Jin, and D. R. Jacobs Jr A Strong Interaction between Serum {gamma}-Glutamyltransferase and Obesity on the Risk of Prevalent Type 2 Diabetes: Results from the Third National Health and Nutrition Examination Survey Clin. Chem., June 1, 2007; 53(6): 1092 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kazemi-Shirazi, G. Endler, S. Winkler, T. Schickbauer, O. Wagner, and C. Marsik Gamma Glutamyltransferase and Long-Term Survival: Is It Just the Liver? Clin. Chem., May 1, 2007; 53(5): 940 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hodgson, N. C. Ward, V. Burke, L. J. Beilin, and I. B. Puddey Increased Lean Red Meat Intake Does Not Elevate Markers of Oxidative Stress and Inflammation in Humans J. Nutr., February 1, 2007; 137(2): 363 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Lee, J. C. Evans, S. J. Robins, P. W. Wilson, I. Albano, C. S. Fox, T. J. Wang, E. J. Benjamin, R. B. D'Agostino, and R. S. Vasan Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ryu, Y. Chang, D.-I. Kim, W. S. Kim, and B.-S. Suh {gamma}-Glutamyltransferase as a Predictor of Chronic Kidney Disease in Nonhypertensive and Nondiabetic Korean Men Clin. Chem., January 1, 2007; 53(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Lee, K. Silventoinen, G. Hu, D. R. Jacobs Jr, P. Jousilahti, J. Sundvall, and J. Tuomilehto Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women Eur. Heart J., September 2, 2006; 27(18): 2170 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Emdin, C. Passino, A. Pompella, and A. Paolicchi Gamma-glutamyltransferase as a cardiovascular risk factor Eur. Heart J., September 2, 2006; 27(18): 2145 - 2146. [Full Text] [PDF]
|
|
|
|
|
|
G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Zoppini, L. Zenari, M. Cigolini, G. Falezza, and G. Arcaro Relations Between Carotid Artery Wall Thickness and Liver Histology in Subjects With Nonalcoholic Fatty Liver Disease. Diabetes Care, June 1, 2006; 29(6): 1325 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Lee, M.-H. Ha, S. Kam, B. Chun, J. Lee, K. Song, Y. Boo, L. Steffen, and D. R. Jacobs Jr. A Strong Secular Trend in Serum Gamma-Glutamyltransferase from 1996 to 2003 among South Korean Men Am. J. Epidemiol., January 1, 2006; 163(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Wannamethee, A. G. Shaper, L. Lennon, and P. H. Whincup Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men Diabetes Care, December 1, 2005; 28(12): 2913 - 2918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Targher, L. Bertolini, F. Poli, S. Rodella, L. Scala, R. Tessari, L. Zenari, and G. Falezza Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Diabetes, December 1, 2005; 54(12): 3541 - 3546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stranges, M. Trevisan, J. M. Dorn, J. Dmochowski, and R. P. Donahue Body Fat Distribution, Liver Enzymes, and Risk of Hypertension: Evidence From the Western New York Study Hypertension, November 1, 2005; 46(5): 1186 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Emdin, A. Pompella, and A. Paolicchi Gamma-Glutamyltransferase, Atherosclerosis, and Cardiovascular Disease: Triggering Oxidative Stress Within the Plaque Circulation, October 4, 2005; 112(14): 2078 - 2080. [Full Text] [PDF]
|
|
|
|
|
|
E. Ruttmann, L. J. Brant, H. Concin, G. Diem, K. Rapp, H. Ulmer, and the Vorarlberg Health Monitoring and Promotion Pro {gamma}-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults Circulation, October 4, 2005; 112(14): 2130 - 2137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Nilssen, M. Averina, T. Brenn, J. Brox, A. Kalinin, and V. Archipovski Alcohol consumption and its relation to risk factors for cardiovascular disease in the north-west of Russia: the Arkhangelsk study Int. J. Epidemiol., August 1, 2005; 34(4): 781 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Kim, D. R. Kang, C. M. Nam, N. W. Hur, J. S. Shim, S. H. Jee, and I. Suh Elevated Serum Aminotransferase Level as a Predictor of Intracerebral Hemorrhage: Korea Medical Insurance Corporation Study Stroke, August 1, 2005; 36(8): 1642 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-H. Lee, D. R. Jacobs Jr, M. Gross, and M. Steffes Serum {gamma}-Glutamyltransferase Was Differently Associated with Microalbuminuria by Status of Hypertension or Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Clin. Chem., July 1, 2005; 51(7): 1185 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Lee, K. Silventoinen, D. R. Jacobs Jr., P. Jousilahti, and J. Tuomileto {gamma}-Glutamyltransferase, Obesity, and the Risk of Type 2 Diabetes: Observational Cohort Study among 20,158 Middle-Aged Men and Women J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5410 - 5414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Fernandez-Real, A. Lopez-Bermejo, M. Broch, J. Vendrell, C. Richart, and W. Ricart Circulating Soluble CD14 Monocyte Receptor Is Associated with Increased Alanine Aminotransferase Clin. Chem., August 1, 2004; 50(8): 1456 - 1458. [Full Text] [PDF]
|
|
|
|
|
|
N. Nakanishi, K. Suzuki, and K. Tatara Serum {gamma}-Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese Men Diabetes Care, June 1, 2004; 27(6): 1427 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-H. Lee, L. M Steffen, and D. R Jacobs Jr Association between serum {gamma}-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study Am. J. Clinical Nutrition, April 1, 2004; 79(4): 600 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-H. Lee, M. D. Gross, and D. R. Jacobs Jr Association of Serum Carotenoids and Tocopherols with {gamma}-Glutamyltransferase: The Cardiovascular Risk Development in Young Adults (CARDIA) Study Clin. Chem., March 1, 2004; 50(3): 582 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-H. Lee, D. R. Jacobs Jr, M. Gross, C. I. Kiefe, J. Roseman, C. E. Lewis, and M. Steffes {gamma}-Glutamyltransferase Is a Predictor of Incident Diabetes and Hypertension: The Coronary Artery Risk Development in Young Adults (CARDIA) Study Clin. Chem., August 1, 2003; 49(8): 1358 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Whitfield, G. Zhu, J. E. Nestler, A. C. Heath, and N. G. Martin Genetic Covariation between Serum {gamma}-Glutamyltransferase Activity and Cardiovascular Risk Factors Clin. Chem., September 1, 2002; 48(9): 1426 - 1431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jousilahti, E. Vartiainen, H. Alho, K. Poikolainen, and P. Sillanaukee Opposite Associations of Carbohydrate-Deficient Transferrin and {gamma}-Glutamyltransferase With Prevalent Coronary Heart Disease Arch Intern Med, April 8, 2002; 162(7): 817 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Emdin, C. Passino, L. Donato, A. Paolicchi, and A. Pompella Serum Gamma-Glutamyltransferase as a Risk Factor of Ischemic Stroke Might Be Independent of Alcohol Consumption Stroke, April 1, 2002; 33(4): 1163 - 1164. [Full Text] [PDF]
|
|
|
|
|
|
M Emdin, C Passino, C Michelassi, F Titta, A L'abbate, L Donato, A Pompella, and A Paolicchi Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction Eur. Heart J., October 1, 2001; 22(19): 1802 - 1807. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Sillanaukee, N. Strid, P. Jousilahti, E. Vartiainen, K. Poikolainen, S. Nikkari, J. P. Allen, and H. Alho Association of self-reported diseases and health care use with commonly used laboratory markers for alcohol consumption Alcohol Alcohol., July 1, 2001; 36(4): 339 - 345. [Abstract] [Full Text] [PDF]
|
|